A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats

被引:72
作者
Overstreet, DH
Knapp, DJ
Moy, SS
Breese, GR
机构
[1] Univ N Carolina, Sch Med, Dept Psychiat, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Dept Pharmacol, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Dept Anesthesiol, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA
关键词
anxiety-like behavior; forced ethanol exposure; repeated ethanol withdrawals; social interaction test; 5-HT1A; 5-HT2C; 5-HT2A receptors;
D O I
10.1007/s00213-003-1425-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Repeated withdrawals from chronic forced ethanol exposure sensitize animals to withdrawal-induced deficits in social interaction behavior. The deficits in social interaction behavior following withdrawal from continuous ethanol exposure can be reduced following acute treatments with 5-HT2C antagonists or 5-HT1A agonists. Objectives: The present study investigated whether prior treatment with these serotonergic agents during early withdrawals in rats subjected to repeated withdrawals from ethanol exposure would ameliorate the social interaction deficits observed following the final withdrawal. Methods: Sprague-Dawley rats were exposed to three cycles of 5 days forced ethanol (7%, w/v), with 2 days of control diet after the first and second cycles. Drugs were administered IP 4 h after removal of ethanol on the first and second cycles but not the third in one group and 4.5 h after removal of ethanol on the third cycle in another. The social interaction test was performed 5 h after removal of ethanol on the third cycle. Drugs tested included SB-242084, a 5-HT2C antagonist; buspirone, a 5-HT1A partial agonist; WAY-100635, a 5-HT1A antagonist; ketanserin, a 5-HT2A antagonist; ritanserin, a mixed 5-HT2A/2C antagonist; and Ro-601075, a 5-HT2C agonist. Results: Both SB-242084 and buspirone reduced ethanol withdrawal-induced deficits in social interaction when given either acutely 30 min before the test or at 4 h after withdrawal from the first and second cycles. WAY-100635 and ketanserin were completely ineffective regardless of mode of treatment. In contrast, the 5-HT2C agonist, Ro-601075, accentuated the withdrawal-induced deficit in social interaction behavior in rats exposed to either 4.5 or 7% ethanol diet. Conclusions: These results support the utility of 5-HT1A agonists and 5-HT2C antagonists in reducing anxiety-like behavior induced by ethanol withdrawal and reducing the adaptive changes associated with repeated withdrawals.
引用
收藏
页码:344 / 352
页数:9
相关论文
共 52 条
[11]   Depression after alcohol treatment as a risk factor for relapse among male veterans [J].
Curran, GM ;
Flynn, HA ;
Kirchner, J ;
Booth, BM .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2000, 19 (03) :259-265
[12]  
DESOTO CB, 1989, ALCOHOL CLIN EXP RES, V13, P693
[13]   THE ROLE OF BUSPIRONE IN THE MANAGEMENT OF ALCOHOL-WITHDRAWAL - A PRELIMINARY INVESTIGATION [J].
DOUGHERTY, RJ ;
GATES, RR .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1990, 7 (03) :189-192
[14]   The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders [J].
Driessen, M ;
Meier, S ;
Hill, A ;
Wetterling, T ;
Lange, W ;
Junghanns, K .
ALCOHOL AND ALCOHOLISM, 2001, 36 (03) :249-255
[15]   Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone [J].
Fawcett, J ;
Kravitz, HM ;
McGuire, M ;
Easton, M ;
Ross, J ;
Pisani, V ;
Fogg, LF ;
Clark, D ;
Whitney, M ;
Kravitz, G ;
Javaid, J ;
Teas, G .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 24 (05) :666-674
[17]  
FILE SE, 1993, ALCOHOL ALCOHOLISM, V28, P495
[18]   A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88
[19]  
FRYE GD, 1983, J PHARMACOL EXP THER, V226, P720
[20]   Buspirone treatment of alcoholism: Age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking [J].
George, DT ;
Rawlings, R ;
Eckardt, MJ ;
Phillips, MJ ;
Shoaf, SE ;
Linnoila, M .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1999, 23 (02) :272-278